Mathias Locher
Corporate Officer/Principal bei Covagen AG
Profil
Mathias Locher is currently the Chief Development Officer at Covagen AG.
Previously, he held the position of Vice President-PreClinical Development at Micromet AG.
From 2007 to 2011, he worked at Merck Serono SA as the Global Head-Drug Metabolism & Pharmacokinetics.
He also served as the Chief Development Officer at Heidelberg Pharma AG from 2021 to 2023.
Dr. Locher obtained a doctorate degree from Eberhard Karls Universität Tübingen.
Aktive Positionen von Mathias Locher
| Unternehmen | Position | Beginn |
|---|---|---|
Covagen AG
 Covagen AG BiotechnologyHealth Technology Covagen AG engages in the research in as well as development, production, and distribution of pharmaceutical and diagnostic products and technologies. The company was founded by Julian Bertschinger and Dragan Grabulovski in 2007 and is headquartered in Zug, Switzerland. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Mathias Locher
| Unternehmen | Position | Ende |
|---|---|---|
| HEIDELBERG PHARMA AG | Corporate Officer/Principal | 01.04.2023 |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Corporate Officer/Principal | 01.01.2011 |
Micromet AG
 Micromet AG Pharmaceuticals: MajorHealth Technology Micromet AG developed, manufactured and marketed novel antibody derived therapeutics for the treatment and control of cancer, inflammatory and autoimmune diseases. It's goal was to commercialize products in these indication areas that have significant unmet medical needs. Founded in 1993, the company was headquartered in Munich, Germany. | Corporate Officer/Principal | - |
Ausbildung von Mathias Locher
| Eberhard Karls Universität Tübingen | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| HEIDELBERG PHARMA AG | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Covagen AG
Covagen AG BiotechnologyHealth Technology Covagen AG engages in the research in as well as development, production, and distribution of pharmaceutical and diagnostic products and technologies. The company was founded by Julian Bertschinger and Dragan Grabulovski in 2007 and is headquartered in Zug, Switzerland. | Health Technology |
Merck Serono SA
Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Health Technology |
Micromet AG
Micromet AG Pharmaceuticals: MajorHealth Technology Micromet AG developed, manufactured and marketed novel antibody derived therapeutics for the treatment and control of cancer, inflammatory and autoimmune diseases. It's goal was to commercialize products in these indication areas that have significant unmet medical needs. Founded in 1993, the company was headquartered in Munich, Germany. | Health Technology |
